How shorter clinical trial processes prolong the lives of people
EY Health Sciences & Wellness podcast series
English - October 20, 2021 18:20 - 29 minutes - 66.9 MB - ★★★★★ - 1 ratingBusiness News News Science health businessmodels healthcare lifesciences medicaltechnology medtech Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: How digital solutions will help close the health equity gap
Next Episode: How data can help redesign the health experience
There are 2,600 cell and gene therapy clinical trials taking place this year. In the US alone, this could translate up to 20 new therapy approvals in 2022, which presents a clear opportunity to make more life-saving therapies available to a greater number of individuals. In this podcast, Adlai Goldberg, Global Digital, Social and Commercial Innovation Life Sciences Leader for EY, talks to Tamie Joeckel – ICON’s Cell and Gene Therapy Global Business Lead, as they discuss what makes an increase in the volume of trials and an acceleration of the clinical trial process significant.